logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy

Boulle A, van Cutsem G, Cohen K, Hilderbrand K, Mathee S,  et al.
2008-08-06 • JAMA
2008-08-06 • JAMA
CONTEXT
Rifampicin-based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well describ...
Journal Article
|
Research

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

Boulle AM, van Cutsem G, Hilderbrand K, Cragg C, Abrahams M,  et al.
2010-02-20 • AIDS
2010-02-20 • AIDS
OBJECTIVES: We report on outcomes after 7 years of a community-based antiretroviral therapy (ART) programme in Khayelitsha, South Africa, with death registry linkages to correct for mort...
Journal Article
|
Commentary

Digital media for distance education

Abrahams M
2014-05-23 • Pediatric Radiology
2014-05-23 • Pediatric Radiology
Journal Article
|
Research

Correcting for Mortality Among Patients Lost to Follow Up on Antiretroviral Therapy in South Africa: A Cohort Analysis

van Cutsem G, Ford NP, Hilderbrand K, Goemaere E, Mathee S,  et al.
2011-02-17 • PLOS One
2011-02-17 • PLOS One
Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) programmes, since it encompasses patients alive but lost to programme and deaths misclassified as LTF. ...